General Catalyst assesses startup financial health by applying a multilayered due diligence framework that blends GAAP compliance, cash dynamics, cap table integrity, grant and tax adherence, and fundraising readiness metrics to produce actionable signals for investment and founder decision-making. This assessment connects directly to outcomes founders care about: extended runway, cleaner investor reporting, faster access to follow-on capital, and compliance across Massachusetts regulatory regimes. The approach General Catalyst uses is particularly relevant for Boston-Cambridge biotech and fintech founders—those spinning out of MIT or Harvard, operating in Kendall Square or the Cambridge Innovation Center, or managing NIH grants and SBIR awards—because it maps technical accounting and regulatory details to venture-backed playbooks and NVCA benchmarks.
Below is a practical, expert-level guide to how General Catalyst and similar top-tier VCs evaluate financial health, written from the perspective of a fractional CFO who frequently prepares startups for that scrutiny. Expect detailed checklists, GAAP-derived controls, grant-management requirements, Massachusetts-specific tax touchpoints, and the operational steps a hired or outsourced CFO would execute to convert gaps into investor-ready strengths.
Transition: Before diving into component-level checks, it helps to understand the high-level framework investors use to synthesize disparate financial signals into a single investment judgment.
High-level framework: what “financial health” means to a lead investor
General Catalyst’s assessment starts from a hypothesis-driven framework: financial health is not an isolated accounting score but a multi-dimensional signal combining liquidity, transparency, scalability of unit economics, governance, and legal/tax/grant risk. The analysis weights each domain by stage—pre-seed and seed focus more on burn and milestones; Series A adds closer scrutiny of revenue recognition, customer metrics, and board governance; later rounds demand audited GAAP statements and repeatable operating margins.
Liquidity and runway as the primary gating factor
At all stages, cash sufficiency is the first filter. Investors evaluate your burn rate (net monthly cash outflow), projected runway under base and downside scenarios, and the liquidity profile of any near-term receivables. GC expects conservative assumptions: at least 12–18 months of runway post-close for Series A companies, with sensitivity tests showing outcomes at -25% revenue or +20% expense variance. A fractional CFO’s immediate role is to produce a clean monthly cash model, categorize discretionary versus fixed spending, and recommend prioritized expense cuts that preserve strategic milestones.
Accounting integrity and GAAP compliance
General Catalyst treats GAAP compliance as binary for investment-grade readiness: either your books reflect GAAP policy choices with documented supporting schedules, or they are a material concern. Common red flags include inconsistent revenue recognition, improper capitalization of R&D or development costs for biotech, and lack of documented accounting policies for stock-based compensation. For founders, having month-end close routines, reconciled balance sheet accounts, and clear audit trails (even pre-audit) is essential. Outsourced CFOs often standardize these processes within 30–90 days to eliminate late-stage surprises.
Governance, reporting cadence, and investor transparency
Investors evaluate how companies communicate financials. A predictable investor reporting cadence—monthly financials, an executive summary with KPIs, and a rolling 12-month cash forecast—is expected. General Catalyst assesses board materials, reporting templates, and whether financial metrics align with business reality. Missing or inconsistent reporting often reduces valuation or demands deal protections. An experienced fractional CFO can bridge the gap by implementing investor-ready packs and enabling logical storylines that link KPIs to milestones.
Transition: Now that the framework is defined, we’ll unpack the core financial statement and accounting checks General Catalyst runs during diligence, and what founders must have prepared.
Financial statements and GAAP depth: what GC inspects and why it matters
General Catalyst inspects three primary reports—balance sheet, income statement, and cash flow statement—looking for GAAP-aligned recognition, reconciliation, and supporting schedules. The goal is to validate that reported performance and projected metrics are materially accurate and auditable, minimizing post-close adjustments.
Balance sheet: capitalization, liabilities, and investor protections
Key focus areas on the balance sheet include properly recorded capital transactions, accurate capitalization of equity and debt instruments, and explicit disclosure of contingent liabilities. GC will corroborate cap table schedules to the equity recorded in the financials, verify debt agreements and warrants, and flag hidden liabilities (lease obligations, deferred rent, or indemnities). For startups with NIH grants or SBIR contracts, deferred revenue and award liabilities must be correctly reflected to avoid mismatches between grant spending and revenue recognition.
Income recognition: revenue, grants, and cost treatment
Revenue recognition is often sector-specific. Fintech startups may have transaction-based revenue requiring precise gross-versus-net judgments; biotech companies recording milestone-based licensing revenue or government grant reimbursements must follow AICPA guidance for contract accounting. General Catalyst examines revenue contracts, revenue-recognition policy memos, and supporting revenue roll-forwards. For SBIR/STTR or NIH awards, GC checks that grant proceeds recognized as revenue match allowable costs and that award-specific restrictions are observed—misapplied grant revenue can trigger clawbacks or audit findings in future funding rounds.
Cash flow statements and burn decomposition
Investors want a transparent decomposition of cash outflows: payroll, R&D spending, capital expenditures, and one-time non-operational items. A clean cash flow statement that reconciles to bank statements reassures VCs about the reliability of runway forecasts. GC will stress-test the burn model, request month-by-month cash forecasts, and look for overly optimistic assumptions about collections or milestone timing.
Stock-based compensation and equity accounting
Equity-based compensation must be accounted for under ASC 718. GC looks for formal grant approvals, proper valuation inputs (for 409A considerations), and amortization schedules. Mis-accounting here impacts both P&L and cap table dilution expectations. For founders in Massachusetts expecting to grant stock options or consider QSBS outcomes, timely 409A valuations and accurate documentation matter for both tax planning and investor comfort.
Transition: After verifying the underpinning financials, General Catalyst evaluates operational metrics and unit economics that predict scalable growth or early attrition risks.
Unit economics, KPIs, and sector benchmarks
Strong unit economics separate investable startups from promising but unscalable ideas. GC breaks down customer-level economics, cohort retention, and growth unit margins, and compares them to NVCA benchmarks appropriate to stage and sector.
Revenue per customer, CAC, LTV, and payback period
Core metrics include Customer Acquisition Cost (CAC), Lifetime Value (LTV), and CAC payback period. For fintech startups, transaction frequency and take-rate matter more than average sale price; for biotech, early revenue may be non-recurring (milestone-based) so GC focuses on pipeline economics and partnership terms. GC expects founders to present clear cohort analyses showing LTV/CAC trends and clear assumptions behind churn and margin expansion.
Gross margin, contribution margin, and scalability
Gross margin trends reveal whether a business can leverage incremental revenue into operating leverage. GC evaluates contribution margin per customer and shows scenario-driven paths to positive gross margins. For software-enabled services in Boston with high initial onboarding costs, GC wants to see a viable path to margin improvement via automation or pricing adjustments.
Biotech-specific KPIs: burn per program, IND timelines, and translational risk
Biotech diligence emphasizes program-level economics: cost-to-IND, expected trial timelines, and dilution requirements to reach key milestones. GC models capital needs across discovery, preclinical, and IND-enabling studies and checks whether NIH or SBIR grant schedules realistically offset program spend. Fractional CFOs can map grant draw schedules to program milestones to reduce the perception of translational risk.
Transition: KPIs are only valuable when owners can explain cap table dynamics and valuation implications; next, we break down how GC inspects the capitalization table and related equity instruments.
Cap table hygiene, valuations, and investor-friendly structures
General Catalyst reviews the cap table for clarity, enforceability, and dilution accuracy. Cap table issues are fast deal blockers because they directly affect ownership, option pools, liquidation preferences, and downstream investor rights. Accurate cap table modeling also informs Series A readiness valuation expectations.
Option pools, reserved equity, and grant practices
GC checks whether the option pool is appropriately sized and whether grants are issued consistently with board approvals and vesting schedules. Unallocated or implicit options create ambiguity during rounds. Founders should provide a waterfall model showing post-money ownership at current and proposed financing scenarios. Outsourced CFOs typically standardize grant documentation and ensure 409A valuations are recent and defensible—critical for option taxation and investor comfort.
Liquidation preferences, anti-dilution, and investor terms
Complex term structures—participating preferred, pay-to-play, or weighted-average anti-dilution—change calculus for exit outcomes. GC models various liquidation scenarios to gauge downside protection and potential founder dilution. Startups that can demonstrate simple, market-standard term profiles (aligned with NVCA guidelines) are evaluated more favorably.
QSBS planning and tax considerations for founders and investors
Qualified Small Business Stock (QSBS) status can materially affect investor and founder outcomes. GC looks for evidence that the company qualifies (C-corp status, eligible active business tests, asset thresholds) and that equity issuances were timely. Fractional CFOs often coordinate early-stage structural choices to preserve QSBS eligibility for founders and early backers, and to align with Massachusetts tax planning.
Transition: With cap table and accounting understood, GC performs a regulatory and tax sweep—especially relevant in Massachusetts where state-specific regimes can affect net cash available to run programs.
Tax, grants, and compliance: Massachusetts and federal nuances
General Catalyst treats tax and grant compliance as low-probability, high-impact risks. In the Boston ecosystem, mistakes around state corporate excise, R&D credits, and SBIR/NHSC award usage can lead to material adjustments or legal exposure. Investors expect visible controls and experienced advisory relationships.
Massachusetts corporate excise and state-level compliance
Massachusetts imposes a corporate excise tax composed of an income measure and a non-income measure (the greater is paid). GC will ask whether the company has filed timely returns, whether nexus rules are understood, and whether payroll and sales tax filings are current. For Cambridge or Boston-based startups, municipal incentives or tax credits might apply, and these must be documented. Misstated tax positions in the state context can create future liabilities that materially affect cash runway.
R&D tax credits and capitalization choices
R&D tax credits can be a meaningful cash benefit, but require methodical documentation of qualified research expenses. GAAP choices on whether to capitalize or expense software development or certain biotech research costs interact with tax positions. GC looks for alignment: the tax positions should not conflict with GAAP in ways that obscure economic reality. Fractional CFOs routinely compile R&D time-tracking, cost pools, and supporting narratives to preserve credit claims.
NIH, SBIR/STTR award management and allowable cost rules
Federal grants have specific allowability rules and funding cycles. GC reviews award agreements, budget modifications, indirect cost rate agreements, and prior audits. Non-compliance with award terms—using funds for unapproved subcontracting, failing to report invention disclosures, or misallocating salaries—can jeopardize future federal funding and raise reputational risk. Grant-backed startups must maintain robust timekeeping, proper cost allocation between restricted and unrestricted activities, and up-to-date subrecipient agreements.
Sales tax, payroll tax, and nexus questions in distributed workforces
The rise of remote work complicates nexus and payroll tax footprints. GC assesses whether the company has inadvertently created tax obligations outside Massachusetts through remote employees, contractors, or licensing activities. Misunderstood nexus can trigger back taxes and penalties; proactive payroll tax registration and consistent contractor classification reduce that risk.
Transition: With compliance under control, General Catalyst examines the organization’s financial controls and reporting processes—areas where fractional CFOs deliver immediate ROI.
Controls, reporting cadence, and the outsourced CFO advantage
Investors judge teams not only by metrics but by the quality of internal controls and reliability of reporting. General Catalyst expects rigor—monthly closes, reconciliations, CAPEX controls, contract repositories, and clear delegations of financial authority. These elements reduce information asymmetry and the perception of execution risk.
Monthly close routines and reconciliation discipline
A repeatable month-end close—bank reconciliations, accrual booking, accounts receivable aging, and cap table reconciliation—creates the foundation for trustworthy reporting. GC will review the month-end checklist and timeliness of reporting. An outsourced CFO often establishes a 10-business-day close target and implements automation to sustain it.
Approval matrices, procurement controls, and fraud prevention
Approval policies for expenditure thresholds, procurement vendors, and contracting reduce leakage and ensure runway predictability. GC reviews expense approval flows and looks for segregation of duties in payment processes. Startups with weak controls often face valuation or terms concessions.
Forecasting discipline: rolling forecasts and scenario planning
GC expects rolling 12-month forecasts updated at least monthly, with scenario variants and clearly documented assumptions. This allows investors to see how decisions (e.g., hiring, facility expansion, or pivoting a program) affect runway and dilution. fractional CFO Boston bring rigor to scenario modeling and tie assumptions to operational levers, enabling faster fundraise preparation and negotiation.
Transition: Controls and forecasting feed directly into fundraising readiness. The next section details what GC specifically flags as readiness criteria for a Series A or follow-on round.
Series A readiness and fundraising diligence: what accelerates favorable outcomes
Preparing for Series A requires both financial hygiene and a credible growth story. General Catalyst’s diligence focuses on repeatability of revenue generation, defensibility of unit economics, and clarity on use of proceeds. Companies that present clean, GAAP-aligned statements, a defensible forecast, and a board-ready governance model are more likely to close quickly and on favorable terms.
What constitutes a clean diligence package
A clean package has: audited or reviewed financial statements if available, detailed monthly management accounts for 12–24 months, bank statements, a reconciled cap table, option grant records, a 12–18 month cash forecast with scenarios, a list of material contracts (customer and vendor), employee offer letters, and a schedule of grant awards or SBIR contracts. Fractional CFOs assemble and maintain this package to reduce friction and speed due diligence timelines.
Valuation drivers and negotiation levers
GC pays attention to defensible growth assumptions and milestone funding needs. Clean accounting reduces perceived risk, often translating into higher pre-money valuations. Conversely, unclear cap tables, unsettled tax positions, or poor grant compliance become negotiation levers that reduce valuations or add protective provisions (e.g., larger liquidation preferences). Demonstrating runway extension strategies—non-dilutive grants, milestone-based vendor payments, or revenue-accelerating partnerships—can improve leverage.
Investor reporting and post-close expectations
Post-close expectations include a monthly financial package, quarterly board materials, and timely updates on hiring, product milestones, and grant utilization. GC often expects the CFO function to be operational from day one; if founders lack an in-house CFO, an experienced fractional CFO is an acceptable and often preferred alternative, provided they can maintain continuity and consistency in reporting.
Transition: Finally, practical operational steps convert this diligence insight into an execution plan that extends runway and improves fundraising outcomes.
Operational playbook: actionable finance steps to meet GC expectations
Founders and fractional CFOs should prioritize high-impact actions that materially change investor perceptions. These tasks shrink diligence timelines, reduce negotiation friction, and improve valuation outcomes.
Immediate 30–90 day fixes
- Implement a monthly close checklist and reconcile all balance sheet accounts. - Produce a conservative 12-month cash forecast with base, downside, and upside scenarios. - Clean the cap table and document all option grants, warrants, convertible notes, and SAFEs; secure or update a 409A valuation. - Prepare an investor-ready pitch financial pack: historical P&L, balance sheet, cash flow, unit economics, and KPI dashboard. - Align grant cost allocations to NIH/SBIR award terms and create audit-ready supporting schedules.
Medium-term 3–6 month improvements
- Establish or refine internal controls: approval matrices, procurement policies, and vendor contracts. - Apply for or document R&D tax credit eligibility and, where advisable, file amended returns to capture missed credits. - Standardize revenue recognition policies and document judgments under GAAP. - Build board-ready materials and a rolling 12–18 month milestone plan tied to cash needs and fundraising objectives. - If in Massachusetts, confirm corporate excise filings and address any nexus or payroll tax exposures created by remote hires.
Longer-term governance and positioning
- Move toward audited financials as you approach a late-Series A or Series B round. - Implement an ERP or integrated accounting stack to scale reporting. - Engage legal counsel to codify stockholder and option plan terms that preserve QSBS eligibility. - Align compensation and hiring plans with modeled unit economics to avoid unsustainable burn.
Transition: To conclude, here is a concise recap and prioritized next steps founders should execute to meet General Catalyst-style diligence expectations.
Concise summary and prioritized next steps
General Catalyst assesses startup financial health through a combined lens of liquidity, GAAP integrity, cap table clarity, regulatory compliance (including Massachusetts tax and federal grant rules), and scalable unit economics benchmarked to NVCA standards. The practical benefits of meeting these expectations are tangible: extended runway, cleaner investor reporting, faster fundraising, and reduced legal/tax risk—especially critical for founders in Kendall Square, Cambridge Innovation Center, and the broader Boston-Cambridge ecosystem.
Immediate priorities: 1) produce a conservative, auditable 12-month cash forecast and month-end close pack; 2) clean and reconcile the cap table and secure a defensible 409A valuation; 3) document grant and R&D tax credit positions and align costs to federal award rules; 4) implement basic internal controls and an investor-ready reporting cadence; 5) model Series A scenarios that show use of proceeds and dilution under realistic cases.
Engaging a seasoned fractional CFO or outsourced CFO will convert these priorities into deliverables quickly, bridging the gap between founder-level recordkeeping and VC-grade readiness. The output: a defensible financial story that shortens diligence timelines, strengthens valuation leverage, and positions the company for durable growth in the Boston-Cambridge biotech and fintech corridors.